Harvard Bioscience Inc (HBIO) — Cash Flow-to-Debt Ratio
Harvard Bioscience Inc (HBIO) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of $-662.00K could theoretically repay 0% of its total liabilities ($67.89 Million) in one year. Explore Harvard Bioscience Inc (HBIO) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Harvard Bioscience Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Harvard Bioscience Inc across 27 annual periods. Also explore Harvard Bioscience Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Harvard Bioscience Inc (1999–2025)
Year-by-year debt coverage analysis for Harvard Bioscience Inc. For market capitalisation and broader financial context, see HBIO stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $6.73 Million | $66.34 Million | ▲ +345.9% |
| 2024 | 0.02x | $1.44 Million | $63.30 Million | ▼ -89.6% |
| 2023 | 0.22x | $14.03 Million | $64.29 Million | ▲ +1285.3% |
| 2022 | 0.02x | $1.15 Million | $73.14 Million | ▼ -1.5% |
| 2021 | 0.02x | $1.26 Million | $78.94 Million | ▼ -86.4% |
| 2020 | 0.12x | $9.33 Million | $79.57 Million | ▲ +21.2% |
| 2019 | 0.10x | $8.05 Million | $83.18 Million | ▲ +254.5% |
| 2018 | 0.03x | $2.34 Million | $85.89 Million | ▼ -26.5% |
| 2017 | 0.04x | $1.06 Million | $28.45 Million | ▼ -75.5% |
| 2016 | 0.15x | $5.38 Million | $35.57 Million | ▲ +814.9% |
| 2015 | 0.02x | $705.00K | $42.62 Million | ▼ -84.6% |
| 2014 | 0.11x | $4.35 Million | $40.45 Million | ▲ +8.6% |
| 2013 | 0.10x | $4.06 Million | $40.98 Million | ▼ -64.0% |
| 2012 | 0.28x | $8.06 Million | $29.27 Million | ▲ +35.1% |
| 2011 | 0.20x | $6.35 Million | $31.14 Million | ▼ -42.7% |
| 2010 | 0.36x | $12.29 Million | $34.55 Million | ▼ -31.1% |
| 2009 | 0.52x | $16.51 Million | $31.97 Million | ▼ -18.3% |
| 2008 | 0.63x | $9.20 Million | $14.55 Million | ▲ +29.6% |
| 2007 | 0.49x | $12.05 Million | $24.72 Million | ▲ +24.6% |
| 2006 | 0.39x | $8.36 Million | $21.34 Million | ▲ +78.0% |
| 2005 | 0.22x | $5.20 Million | $23.62 Million | ▼ -31.7% |
| 2004 | 0.32x | $11.44 Million | $35.52 Million | ▲ +369.2% |
| 2003 | 0.07x | $2.03 Million | $29.55 Million | ▲ +64.8% |
| 2002 | 0.04x | $799.46K | $19.20 Million | ▼ -84.2% |
| 2001 | 0.26x | $4.10 Million | $15.55 Million | ▼ -20.6% |
| 2000 | 0.33x | $2.15 Million | $6.47 Million | ▲ +43.0% |
| 1999 | 0.23x | $2.93 Million | $12.63 Million | — |